NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Journey Medical Corporation Sitemap
Browse the links below for pages that make up the Journey Medical Corporation website.
NOW APPROVED
Journey Medical Corporation Announces the U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg for Treatment of Papulopustular Rosacea.
Sitemap
We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.